James E Klaunig

9PUBLICATIONS
12CO-AUTHORS
Molecular targetsPhotonic and electro-optical devices, sensors and systems (excl. communications)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Aerodynamics (excl. hypersonic aerodynamics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 30, 2024
Mode of action of dieldrin-induced liver tumors: application to human risk assessment.

James E Klaunig, Samuel M Cohen

|Jun 06, 2024
Nicotine or marijuana vaping exposure during pregnancy and altered immune responses in offspring.

Jonas M Ndeke, James E Klaunig, Sarah Commodore

|Mar 25, 2024
Assessment of the mode of action of perchloroethylene-induced mouse liver tumors.

James E Klaunig, Christopher Bevan, Bhaskar Gollapudi

|Mar 18, 2024
Evaluating the mode of action of perfluorooctanoic acid-induced liver tumors in male Sprague-Dawley rats using a toxicogenomic approach.

Xilin Li, Zemin Wang, Qiangen Wu

|Jun 07, 2023
Evaluation of the carcinogenicity of carbon tetrachloride.

Samuel M Cohen, Christopher Bevan, Bhaskar Gollapudi

|Apr 07, 2023
miR-34a regulates macrophage-associated inflammation and angiogenesis in alcohol-induced liver injury.

Ying Wan, Elise Slevin, Sachiko Koyama

Pageof 2